Showing 97–108 of 226 results
Presented by Dr. Alexander Baumann Head of European Business Development Eurofins DiscoverXProducts
Read MoreJane E. Lamerdin, Ph.D. Vice President, Research & Development Eurofins DiscoverX
Read MoreGaurav Agrawal, Ph.D.Scientific Development Manager
Read MoreThe screening and functional characterization of novel ligands for G-protein-coupled receptors (GPCRs) remains a key activity in drug discovery process.…
Read MoreAntibody-dependent cell-mediated cytotoxicity (ADCC) is the mechanism by which many Class I therapeutic antibodies, including rituximab and trastuzumab, achieve clinical…
Read MoreAn Application Note Assessing the Regulation of Mast Cell Function and its Implications in Safety Pharmacology. MrgprX2 antagonism promotes fresh…
Read MoreAs more is learned about the intricacies of GPCR signaling, the harder it becomes to accurately describe ligand activity using…
Read MorePresented by Jane Lamerdin, Ph.D. March 9, 2017 BEBPA 2017, San Francisco, CA
Read MoreDrug Discovery for Ion Channels XXIII Satellite Meeting
Read MoreWatch Recorded Presentation Jane Lamerdin, Ph.D. Director R&D, Eurofins DiscoverX
Read MoreKsenya Cohen Katsenelson, Ph.D. Group Leader, R&D, San Diego Chao-Tsung Yang, Ph.D. Principal Scientist, R&D, Fremont
Read More
